SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Skywatcher who wrote (846)11/21/1997 4:03:00 AM
From: Skywatcher   of 7041
 
Mention in Motley Fool Lunchtime
Impotency pill company Zonagen Inc. (Nasdaq:ZONA) fought claims by Asensio & Co. that late-stage trials of its pill were flawed, which helped the stock $3 1/8 to $31 5/8. A spokesman for the company said
Vasomax was properly tested and had proved effective and safe in four completed late-stage trials involving 1100 patients.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext